Production and Purification of Human GPC2

Heitzeneder S., Bosse K.R., Zhu Z., Zhelev D., Majzner R.G., Radosevich M.T., Dhingra S., Sotillo E., Buongervino S., Pascual-Pasto G., Garrigan E., Xu P., Huang J., Salzer B., Delaidelli A., Raman S., Cui H., Martinez B., Bornheimer S.J., Sahaf B., Alag A., Fetahu I.S., Hasselblatt M., Parker K.R., Anbunathan H., Hwang J., Huang M., Sakamoto K., Lacayo N.J., Klysz D.D., Theruvath J., Vilches-Moure J.G., Satpathy A.T., Chang H.Y., Lehner M., Taschner-Mandl S., Julien J.P., Sorensen P.H., Dimitrov D.S., Maris J.M, & Mackall C.L. (2021). GPC2-CAR T Cells Tuned for Low Antigen Density Mediate Potent Activity Against Neuroblastoma Without Toxicity.. Cancer cell, 40(1), 53-69.e9.